Literature DB >> 9063497

Plasminogen activators and inhibitors in peritoneal tissue.

L Holmdahl1, M Falkenberg, M L Ivarsson, B Risberg.   

Abstract

Serosal trauma elicits an inflammatory response which leads to the deposition of fibrin at injured sites, the residuals of which appear to be essential in excessive tissue repair and formation of intraabdominal adhesions. Local plasminogen activity may modulate this early phase of tissue repair. The present study was undertaken to investigate the distribution and cellular expression of plasminogen activators and their inhibitors in human peritoneal normal and inflamed tissue. Tissue-type plasminogen activator (t-PA) was expressed in subserosal capillary walls, and in normal mesothelium, but not in inflammation. Immunoreactivity for the plasminogen activator inhibitor type 1 (PAI-1) was present in normal mesothelium, and substantially increased in inflammation, where, in addition, immunoreactivity was found throughout the submesothelial tissue. This PAI-1 was partly co-localized with macrophages, as was the urokinase plasminogen activator (u-PA), suggesting an involvement of these cells in peritoneal tissue fibrinolysis. Inflammation or abrasion of the mesothelium during surgery is likely to cause a depletion of the local t-PA source and expose the potentially PAI-1-containing submesothelial tissue, thus promoting persistence of fibrin and formation of adhesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063497     DOI: 10.1111/j.1699-0463.1997.tb00535.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  13 in total

Review 1.  Prevention of peritoneal adhesions: a promising role for gene therapy.

Authors:  Hussein M Atta
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Authors:  Deirisa Lopes Barreto; Annemieke M Coester; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

3.  The effect of opioids on the development of postoperative intra-abdominal adhesions.

Authors:  Amir Khorram-Manesh; Jalal Vahedian Ardakani; Hamid Reza Behjati; Gunnar Nylund; Dick Delbro
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

4.  The use of statins in postoperative adhesion prevention.

Authors:  J B C van der Wal; J Jeekel
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 5.  Polymers in the prevention of peritoneal adhesions.

Authors:  Yoon Yeo; Daniel S Kohane
Journal:  Eur J Pharm Biopharm       Date:  2007-07-20       Impact factor: 5.571

6.  A neurokinin 1 receptor antagonist decreases adhesion reformation after laparoscopic lysis of adhesions in a rat model of adhesion formation.

Authors:  S G Prushik; C B Aarons; R Matteotti; K L Reed; A C Gower; S E Leeman; A F Stucchi; J M Becker
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 4.584

7.  The role of aerosolized intraperitoneal heparin and hyaluronic acid in the prevention of postoperative abdominal adhesions.

Authors:  Nawar A Alkhamesi; Christopher M Schlachta
Journal:  Surg Endosc       Date:  2013-07-23       Impact factor: 4.584

8.  Heating of carbon dioxide during insufflation alters the peritoneal fibrinolytic response to laparoscopic surgery : A clinical trial.

Authors:  W J A Brokelman; L Holmdahl; M Bergström; P Falk; J H G Klinkenbijl; M M P J Reijnen
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

9.  A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity.

Authors:  Karen L Reed; A Brent Fruin; Adam C Gower; Arthur F Stucchi; Susan E Leeman; James M Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

10.  Towards gene therapy of postoperative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells.

Authors:  S Nair; G M Saed; H M Atta; V Rajaratnam; M P Diamond; D T Curiel; A Al-Hendy
Journal:  Gynecol Obstet Invest       Date:  2013-08-06       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.